🔴 Revolution Medicines is trading 4.3% down today amid broad biotech-sector weakness

Revolution Medicines is trading 4.3% down now at $196.10, mainly amid biotechnology-sector weakness.

• No new negative company-specific announcement emerged on September 16, 2026; XBI is down 2.11%.
• Cautious market sentiment surrounding the Federal Reserve’s rate hike, elevated Treasury yields, and persistent inflation also pressured the sector.
• The FDA granted RASONQUE Breakthrough Therapy Designation on September 14, making sector-wide pressure the more likely explanation.